Fig. 3 | Scientific Reports

Fig. 3

From: TMEM101 expression and its impact on immune cell infiltration and prognosis in hepatocellular carcinoma

Fig. 3

Promoter methylation level of TMEM101 in HCC (UALCAN). (A) Promoter methylation level of TMEM101 in normal and HCC patients. (B–I) TMEM101 promoter methylation levels of HCC patients in subgroups with different genders, ages, individual cancer stages, tumor grades, races, weights, nodal metastasis status, and TP53 mutation status. Data are shown as mean ± SE. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

Back to article page